Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice

Journal of Clinical Investigation

Volumn 115, Issue 8, 2005, Pages 2192-2201

  Moore, Kathryn J ^a   Kunjathoor, Vidya V ^a   Koehn, Stephanie L ^a   Manning, Jennifer J ^a   Tseng, Anita A ^a   Silver, Jessica M ^a   McKee, Mary ^a   Freeman, Mason W ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD36 ANTIGEN; CHOLESTEROL ESTER; LIPID; OXIDIZED LOW DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR; SCAVENGER RECEPTOR A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; ATHEROGENIC DIET; ATHEROSCLEROSIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; FOAM CELL; GENE DELETION; HYPERLIPIDEMIA; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIPID TRANSPORT; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN MODIFICATION; RECEPTOR BINDING;

ANIMALS; ANTIGENS, CD36; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; CHOLESTEROL ESTERS; DIET, ATHEROGENIC; FOAM CELLS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; RECEPTORS, IMMUNOLOGIC; RECEPTORS, SCAVENGER; SCAVENGER RECEPTORS, CLASS A; SINUS OF VALSALVA;

EID: 23644435612     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI24061     Document Type: Article

References (47)

1. Endemann, G., et al. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268:11811-11816.
2. Brown, M.S., Goldstein, J.L., Krieger, M., Ho, Y.K., and Anderson, R.G. 1979. Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins. J. Cell Biol. 82:597-613.
3. Brown, M.S., Basu, S.K., Falck, J.R., Ho, Y.K., and Goldstein, J.L. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J. Supramol. Struct. 13:67-81.
4. Matsumoto, A., et al. 1990. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc. Natl. Acad. Sci. U. S. A. 87:9133-9137.
5. de Winther, M.P., et al. 1999. Scavenger receptor deficiency leads to more complex atherosclerocic lesions in APOE3Leiden transgenic mice. Atherosclerosis. 144:315-321.
6. Sakaguchi, H., et al. 1998. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab. Invest. 78:423-434.
7. Babaev, V.R., et al. 2000. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler. Thromb. Vasc. Biol. 20:2593-2599.
8. Febbraio, M., et al. 2000, Targeted disruption of the class B scavenger receptor CD36 ptorects against atherosclerotic lesion development in mice. J. Clin. Invest. 105:1049-1056.
9. Suzuki, H., et al. 1997. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 386:292-296.
10. Williams, K.J., and Tabas, I. 1995. The response-roretention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15:551-561.
11. Skalen, K., et al. 2002. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature. 417:750-754.
12. Kruth, H.S. 2002. Sequestration of aggregated low-density lipoproteins by macrophages. Curr. Opin. Lipidol 13:483-488.
13. Kruth, H.S., et al. 2005. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native LDL. J. Biol. Chem. 280:2352-2360.
14. Onitiri, A.C., et al. 1976. Lipoprotein concentrations in serum and in biopsy samples of arterial intima: a quantitive comparison. Atherosclerosis. 23:513-519.
15. Smith, E.B., and Ashall, C. 1983. Low-density lipoprotein concentration in interstitial fluid from human atherosclerotic lesions. Relation to theories of endothelial damage and lipoprotein binding. Biochim. Biophys. Acta. 754:249-257.
16. Kunjathoor, V.V., et al. 2002. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277:49982-49988.
17. Van Eck, M., et al. 2000. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on cholesterol levels and atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 20:2600-2606.
18. Wolle, S., Via, D.P., Chan, L., Cornicelli, J.A., and Bisgaier, C.L. 1995. Hepatic overexpression of bovine scavenger receptor type I in transgenic mice prevents diet-induced hyperbetalipoproteinemia. J. Clin. Invest. 96:260-272.
19. Medeiros, L.A., et al. 2004. Fibrillar amyloid protein present in atheroma activates CD36 signal transduction. J. Biol. Chem. 279:10643-10648.
20. Moore, K.J., et al. 2002. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 277:47373-47379.
21. El Khoury, J.B., et al. 2003. CD36 mediates the innate host response to beta-amyloid. J. Exp. Med. 197:1657-1666.
22. Kruth, H.S. 2001. Macrophage foam cells and atherosclerosis. Front. Biosci. 6:D429-D455.
23. Kruth, H.S., Huang, W, Ishii, I., and Zhang, W.Y. 2002. Macrophage foam cell formation with native low density lipoprotein. J. Biol. Chem. 277:34573-34580.
24. Zalewski, A., and Macphee, C. 2005. Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target. Arterioscler. Thromb. Vasc. Biol. 25:923-931.
25. Klimov, A.N., et al. 1985. Lipoprotein-antibody immune complexes. Their catabolism and role in foam cell formation. Atherosclerosis. 58:1-15.
26. Griffith, R.L., Virella, G.T., Stevenson, H.C., and Lopes-Virella, M.F. 1988. Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J. Exp. Med. 168:1041-1059.
27. Llorente-Cortes, V., Martinez-Gonzalez, J., and Badimon, L. 2000. LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20:1572-1579.
28. Morita, S.Y., et al. 2004. Ceramide in lipid particles enhances heparan sulfate proteoglycan and Low density lipoprotein receptor-related protein-mediated uptake by macrophages. J. Biol. Chem. 279:24355-24361.
29. Freeman, M., et al. 1991. Expression of type 1 and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc. Natl. Acad. Sci. U.S. A. 88:4931-4935.
30. Rohrer, L., Freeman, M., Kodama, T., Penman, M., and Krieger, M. 1990. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 343:570-572.
31. Salvayre, R., Auge, N., Benoist, H., and Negre-Salvayre, A. 2002. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta. 1585:213-221.
32. Febbraio, M., Guy, E., and Silverstein, R.L. 2004. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24:2333-2338.
33. Reardon, C.A., Blachowicz, L., Lukens, J., Nissenbaum, M., and Getz, G.S. 2003. Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe. Arterioscler. Thromb. Vasc. Biol. 23:1449-1454.
34. Dansky, H.M., et al. 1999. Genetic background determines the extent of atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19:1960-1968.
35. Zhao, Z., et al. 2005. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler. Thromb. Vasc. Biol. 25:168-173.
36. Whitman, S.C., Rateri, D.L., Szilvassy, S.J., Cornicelli, J.A., and Daugherty, A. 2002. Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology. J. Lipid Res. 43:1201-1208.
37. De Winther, M.P., Gijbels, M.J., Van Dijk, K.W., Havekes, L.M., and Hofker, M.H. 2000. Transgenic mouse models to study the role of the macrophage scavenger receptor class A in atherosclerosis. Int. J. Tissue React. 22:85-91.
38. Herijgers, N., et al. 2000. Effect of human scavenger receptor class A overexpression in bone marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice. J. Lipid Res. 41:1402-1409.
39. Teupser, D., et al. 1999. Scavenger receptor activity is increased in macrophages from rabbits with low atheroscierotic response: studies in normochoiesteroiemic high and low atherosclerotic response rabbits. Arterioscler. Thromb. Vasc. Biol. 19:1299-1305.
40. Friedman, G., et al. 1997. Scavenger receptor activity and expression of apolipoprotein E mRNA in monocyte-derived macrophages of young and old. healthy men. Atherosclerosis. 128:67-73.
41. Bjorkbacka, H., et al. 2004. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10:416-421.
42. Moore, K.J., et al. 2001. The role of PPAR-gamma in macrophage differentiation and cholesterol uptake. Nat. Med. 7:41-47.
43. Zhang, W.Y., Gaynor, P.M., and Kruth, H.S. 1997. Aggregated low density lipoprotein induces and enters surface-connected compartments of human monocyte-macrophages. Uptake occurs independently of the low density lipoprotein receptor. J. Biol. Chem. 272:31700-31706.
44. Kunjathoor, V.V., Wiison, D.L., and LeBoeuf, R.C. 1996. Increased atherosclerosis in screptozotocin-induced diabetic mice. J. Clin. Invest. 97:1767-1773.
45. Kunjathoor, V.V., Chiu, D.S., O'Brien, K.D., and LeBoeuf, R.C. 2002. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 22:462-468.
46. van Vlijmen, B.J., et al. 1994. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J. Clin. Invest. 93:1403-1410.
47. Kanters, E., et al. 2003. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 112:1176-1185. doi:10.1172/JCI200318580.